Baseline Assessment - Accelerating New Standards of Oncology Care Amidst the Global Pandemic

Launch Date:
March 31, 2021
Expiration Date:
The accreditation for this activity has expired.
Return to Enrollment Page

Primary Audience:

Medical oncologists, oncology nurses, oncology physician assistants, oncology nurse practitioners, and pharmacists

Relevant Terms:

Oncology, hematology, COVID-19, shared decision-making, telehealth, telemedicine, technology, well-being, self-care, mindfulness

OVERVIEW

This self-assessment will assess your understanding of cancer care during the COVID-19 pandemic, including implementing guidelines and recommendations, integrating telehealth services, and supporting oncology team well-being.

FACULTY

Diane Barber, PhD, APRN, ANP-BC, AOCNP

Manager, Advanced Practice Providers
Department of Investigational Cancer Therapeutics
University of Texas MD Anderson Cancer Center
Houston, Texas

Diane Barber, PhD, APRN, ANP-BC, AOCNP, is the Manager of Advanced Practice Providers in the Department of Investigational Cancer Therapeutics at the University of Texas MD Anderson Cancer Center in Houston, Texas. She received her Bachelor of Science in Nursing degree from the University of Hawaii at Manoa in Honolulu, Hawaii. She then completed her Master of Science in Nursing from the University of Pennsylvania in Philadelphia, Pennsylvania, followed by her Doctorate in Nursing from the University of Texas at Tyler in Tyler, Texas. 
 
Dr Barber has more than 30 years of nursing experience in general surgery, orthopedics, and oncology. She has authored several peer-reviewed articles and has presented nationally and internationally on oncology-related topics. Her current research interest is the role of advanced practice providers in the outcomes of patients with cancer.
 

Pelin Cinar, MD, MS 

Associate Clinical Professor of Oncology   
Medical Director, Quality and Safety
Helen Diller Family Comprehensive Cancer Center
University of California San Francisco 
San Francisco, California

Pelin Cinar, MD, MS, is an Associate Clinical Professor specializing in gastrointestinal oncology with an interest in pancreatic cancer at the University of California San Francisco (UCSF). She also serves as the Medical Director of Quality and Safety at UCSF Helen Diller Family Comprehensive Cancer Center (HDFCCC). In this role, she oversees all internal and external quality improvement and patient safety initiatives related to cancer. 
 
Dr Cinar earned her medical degree and completed her residency in internal medicine at the University of California, Irvine. She received her fellowship training in hematology and oncology at UCSF, where she was appointed chief fellow. 
 
In 2014, Dr Cinar joined the faculty of the Stanford Cancer Center as a gastrointestinal oncologist. She was also Assistant Medical Director for Cancer Care Quality and Associate Director for Quality and Curriculum for the Oncology Fellowship Program at Stanford. In 2015, she was selected to participate in the American Society of Clinical Oncology’s Quality Training Program. She currently serves as a faculty/coach for this program. In 2016, she was recruited back to UCSF to develop the Quality and Safety Program for the UCSF Cancer Center. During the COVID-19 pandemic, Dr Cinar led the response and mitigation strategies at UCSF HDFCCC.
 
In addition to her role at UCSF, Dr Cinar leads the quality efforts for the UC Cancer Consortium, a consortium of the 5 University of California Comprehensive Cancer Centers. She also serves as an Associate Editor for JCO Oncology Practice. 

Kirollos S. Hanna, PharmD, BCPS, BCOP

Assistant Professor of Pharmacy
Mayo Clinic College of Medicine
Rochester, Minnesota
Oncology Pharmacy Manager, M Health Fairview – Maple Grove
Maple Grove, Minnesota

Kirollos S. Hanna, PharmD, BCPS, BCOP, is Assistant Professor of Pharmacy at the Mayo Clinic College of Medicine in Rochester, Minnesota, and the Oncology Pharmacy Manager at M Health Fairview – Maple Grove in Maple Grove, Minnesota. Dr Hanna received his doctorate of pharmacy from Florida A&M University. He then completed his PGY1 pharmacy practice residency at St. Thomas Hospital in Nashville, Tennessee, followed by his PGY2 oncology residency at St. Luke’s Mountain States Tumor Institute in Boise, Idaho. He is board certified by the Board of Pharmacy Specialties in Oncology Pharmacy and Pharmacotherapy.
Dr Hanna’s research interests are focused on B-cell malignancies and genitourinary cancers. He has published more than a dozen peer-reviewed manuscripts in various journals, including Pharmacotherapy, American Journal of Health-System Pharmacy, Drugs, Journal of Oncology Pharmacy Practice, American Journal of Managed Care, and Journal of Hematology Oncology Pharmacy. He is also an active member of the Hematology/Oncology Pharmacy Association, Association of Community Cancer Centers, Patient-Centered Outcomes Research Institute, Aplastic Anemia and MDS International Foundation, and American College of Clinical Pharmacy. 

LEARNING OBJECTIVES

1.
INITIATE action plans to implement strategies that address COVID-19-related cancer care guidelines into practice.
2.
ORGANIZE teams to initiate the integration of telehealth services into oncology practice
3.
PROMOTE practices to support oncology team well-being during the COVID-19 pandemic

GENERAL INFORMATION

PROGRAM TITLE

Accelerating New Standards of Oncology Care Amidst the Global Pandemic: Operational, Clinical, and Interpersonal Considerations


PROVIDERSHIP & SUPPORT

This educational activity is jointly provided by Albert Einstein College of Medicine-Montefiore Medical Center and Spire Learning.

 

This activity is supported by educational grants from Eisai Inc., GlaxoSmithKline LLC, Lilly USA, LLC, Merck & Co, Inc., Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.


PROGRAM OVERVIEW

The COVID-19 pandemic has significantly affected nearly every aspect of oncological practice because of the increased risk to patients with cancer and the impact on health care resources. This has led to rapid changes in when, where, and how to provide diagnostic procedures, treatment, and follow-up care. There is an urgent need to provide cancer care professionals with guidance, training, and support as they respond to unprecedented challenges in maintaining high-quality patient care. This educational activity will help oncology care teams maintain high-quality care in light of the pressing demands of the COVID-19 pandemic. 


TARGET AUDIENCE

This educational initiative is designed for medical oncologists, oncology nurses, oncology physician assistants, oncology nurse practitioners, and pharmacists involved in the care of patients with cancer during the COVID-19 pandemic.


ACCREDITATION AND CREDIT DESIGNATION

In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and Spire Learning. Albert Einstein College of Medicine-Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.

 

Credit Designation Statements:

Physicians: Albert Einstein College of Medicine-Montefiore Medical Center designates this other (blended live and enduring curriculum) activity for a maximum of 3.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses: The maximum number of hours awarded for this Continuing Nursing Education activity is 3.5 contact hours.

Pharmacists: This knowledge-based activity UAN # JA4008224-9999-21-005-H01-P qualifies for 3.5 contact hours (0.350 CEUs) of continuing pharmacy education credit.

Pharmacists should claim only the credit commensurate with the extent of their participation in the activity.

For submission of Pharmacist CE credit to CPE Monitor, please ensure your RealCME registration is updated with your birthdate and NABP ID number.

IPCE Credit: This activity was planned by and for the healthcare team, and learners will receive 3.5 Interprofessional Continuing Education (IPCE) credits for learning and change.


INSTRUCTIONS ON HOW TO RECEIVE CREDIT

There is no fee to participate in this activity. In order to receive CME/CE credit, you must complete:

• Baseline Assessment

• Modules 1, 2, and 3

• Group Task

• Two Live Web Meetings

• Group Discussion Forum

• Final Assessment

• Activity Evaluation

Your certificate can be printed immediately.


CONTACT INFORMATION

For questions regarding CE credit, contact Albert Einstein College of Medicine-Montefiore Medical Center at cme@montefiore.org.

For technical questions related to this activity, please contact support@gathered.com.


CONFLICT OF INTEREST STATEMENT

The “Policy on Collection of Relevant Financial Relationships and Resolution of COI” of Albert Einstein College of Medicine-Montefiore Medical Center requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest.* Albert Einstein College of Medicine-Montefiore Medical Center resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational activities. Any presenter whose disclosed relationships prove to create a conflict of interest with regard to their contribution to the activity will not be permitted to present.

Albert Einstein College of Medicine-Montefiore Medical Center also requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

*The ACCME defines a Commercial Interest as an entity producing, marketing, re-selling or distributing health care goods or services consumed by or used on patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests - unless the provider of the clinical service is owned, or controlled by, an ACCME-defined commercial interest.

Albert Einstein College of Medicine-Montefiore Medical Center resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational activities.


Summary of Individual Disclosures

All individuals influencing content for this activity were asked to disclose relationships with commercial interests within the past 12 months.


FACULTY CO-CHAIRS

Diane Barber, PhD, APRN, ANP-BC, AOCNP
Manager, Advanced Practice Providers
Department of Investigational Cancer Therapeutics
University of Texas MD Anderson Cancer Center
Houston, Texas

Disclosure: Dr Barber has no relevant conflicts of interest with any ACCME-defined commercial interest.


Pelin Cinar, MD, MS
Associate Clinical Professor of Oncology
Medical Director, Quality and Safety
Helen Diller Family Comprehensive Cancer Center
University of California San Francisco 
San Francisco, California

Disclosures: Dr Cinar has the following relevant disclosure: 

Consultant: Astellas Pharma US, Inc


Kirollos S. Hanna, PharmD, BCPS, BCOP
Assistant Professor of Pharmacy
Mayo Clinic College of Medicine
Rochester, Minnesota
Oncology Pharmacy Manager, M Health Fairview – Maple Grove
Maple Grove, Minnesota

Disclosure: Dr Hanna has the following relevant disclosures: :

Advisor or Consultant: Seagen Inc

Speaker: AbbVie Inc; Astellas Pharma US, Inc; BeiGene; Bristol Myers Squibb Company

The faculty have indicated that their financial relationships will not impact their ability to discuss material that is balanced, nonbiased, accurate, current, and scientifically rigorous.


EDUCATION PLANNING COMMITTEE

Rasim Gucalp, MD, FACP (Peer Reviewer)
Professor, Department of Medicine (Oncology)
Albert Einstein College of Medicine
Director, Hematology/Oncology Fellowship Program
Montefiore Medical Center
Bronx, New York

Disclosure: Dr. Gucalp has no relevant conflicts of interest with any ACCME-defined commercial interest.


Rhoda San Jose, DNP, MS, RN, NPD-BC, CHSE (Peer Reviewer)
Manager of Clinical Learning, Continuing Education, and Simulation
Nurse Residency Program Coordinator
Montefiore Learning Network
Albert Einstein College of Medicine-Montefiore Medical Center
Bronx, NY

Disclosure: Rhoda San Jose, DNP, MS, RN, NPD-BC, CHSE  has no relevant conflicts of interest with any ACCME-defined commercial interest.


Victor B. Hatcher, PhD (CE Reviewer)
Associate Dean, Continuing Professional Development
Albert Einstein College of Medicine
Montefiore Medical Center
Bronx, NY

Disclosure: Victor B. Hatcher, PhD has no relevant conflicts of interest with any ACCME-defined commercial interest.

Spire Learning

Ashton Webb, PharmD, BCACP; Chad Thompson; and Lisa Colombo have no relevant conflicts of interest with any ACCME-defined commercial interest. 

Katherine DiPalo, PharmD, FAHA, FHFSA, BCACP, BCGP (CPE Reviewer)
Assistant Professor, Department of Medicine (Hospital Medicine)
Albert Einstein College of Medicine
Clinical Program Manager
Hospital Readmissions Reduction Program
Montefiore Medical Center
Bronx, NY

Disclosure: Dr. Katherine DiPalo has no relevant conflicts of interest with any ACCME-defined commercial interest.


DISCLOSURE OF UNLABELED USE 

This educational activity will not contain discussion of the unlabeled/unapproved use of agents or classes for COVID-19 or cancer care. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


DISCLAIMER 

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.


PRIVACY POLICY

Albert Einstein College of Medicine-Montefiore Medical Center, Center for Continuing Professional Development (Einstein-Montefiore CCPD) protects the privacy of personal and other information regarding participants and education collaborators. Einstein-Montefiore CCPD will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting to the ACCME.

Einstein-Montefiore CCPD maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse, or alteration of information collected from you.

Additional information regarding Albert Einstein College of Medicine-Montefiore Medical Center’s Privacy Policy can be viewed at https://www.mecme.org/PrivacyStatement.aspx 

Spire Learning, LLC is committed to protecting the privacy of personal information from our participants and educational collaborators. Spire maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse, or alteration of personal information.

Collection and Use of Your Personal Information

The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing an activity. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of each activity. All evaluative information submitted is collected, retained, and used by Spire Learning, LLC to continuously improve the learning experience.

Spire Learning, LLC will not transfer, sell, or share personal information with outside parties or otherwise disclose personal information unless required to in a legal process. Spire will retain your personal data only for the period necessary to accomplish the stated purposes and to comply with applicable laws.

 

COPYRIGHT STATEMENT

Copyright © 2021 by Spire Learning, LLC and its Licensors. All rights reserved. No part of this publication or activity may be reproduced or transmitted in any form, by any means, without prior written permission of Spire Learning, LLC. Spire Learning, LLC and Albert Einstein College of Medicine-Montefiore Medical Center, Center for Continuing Professional Development (Einstein-Montefiore CCPD) will not assume responsibility for damages, loss, or claims of any kind arising from or related to the information contained in this publication or activity, including any claims related to the products, drugs, or services mentioned herein.